Generally, circulating IL-6 levels were found to correlate with systemic inflammatory responses in CRC patients undergoing surgery [40], and it has broad functions in CRC development, such as in promoting tumor growth [41], spreading [42], and angiogenesis [43], as well as in regulating treatment resistance [44, 45]. Here, IL6 is linked to colorectal carcinoma.